The 14-3-3 zeta recombinant protein was used as a coating antigen in enzyme-linked immunosorbent assay (ELISA) to screen for an autoantibody against 14-3-3 zeta in sera from patients with LC, CH, and NHS. Here, YWHAQ is linked to laryngotracheoesophageal cleft.